The independent source for health policy research, polling, and news.
1,181 - 1,200 of 112,370 Results
Pazdur will head the FDA's Center for Drug Evaluation and Research, replacing George Tidmarsh. Other pharma news is on telehealth prescriptions for certain controlled substances, health information privacy related to wearable devices and mobile health apps, and more.
A new report points to 27 completed or planned labor and delivery unit closures this year. Other industry news is on Genesis HealthCare, the fight between Blue Cross Blue Shield of Massachusetts and the UMass Memorial Health system, pediatric ER care, and more.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health topics.
The Task Force on Responsible Use of Natural Psychedelic Substances submitted its report on the benefits of easing restrictions on psilocybin, mescaline, and dimethyltryptamine, three natural psychedelics. Also in the news: Colorado, Ohio, Connecticut, North Carolina, Texas, California, and Louisiana.
Merck's new pill, enlicitide, and Amgen's longtime Repatha shot are showing heart attack risk-lowering potential, and researchers have made progress on the gene-editing front.
Eight senators voted with the Democratic caucus to advance a compromise measure to fund the government through the end of January. SNAP benefits would resume, but the extension of health care tax credits is not included. Plus, President Trump renews call to repeal Obamacare.
On Sunday night, an appeals court denied President Donald Trump's efforts to halt the release of full funding for November's payments. Trump also threatened Friday to penalize states that paid full benefits and ordered them to claw back the money. It's unclear if that demand still stands.
There's no specific plan for the payments, which Congress would likely need to approve. Meanwhile, the Supreme Court is hearing arguments about whether Trump overstepped his authority in levying tariffs without congressional support. Plus: Would 50-year mortgages help the housing crisis?
Researchers also found higher risks of chronic rhinitis, chronic rhinosinusitis, and nasal polyposis. Also, ByHeart baby formula has been recalled due to a multistate outbreak of infant botulism. Plus, research shows 1 in 27 women are informally sharing breast milk.
Today's early morning highlights from the major news organizations.
Editorial writers examine these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on peanut allergies, nutrition, SAD, ELISA testing, and more.
Half of the money will be divided equally among all states with approved applications, while the other $25 billion will be awarded at the discretion of CMS chief Mehmet Oz and will be based on criteria such as whether the states have adopted MAHA policies. Also: AI-powered prior authorization programs; a nurse staffing agency challenges the $100K visa fee; and more.
The Supreme Court let stand a Trump administration policy that bars people from updating their gender markers. One ACLU director quickly denounced the decision, calling it an "attempt to dehumanize, humiliate, and endanger transgender, nonbinary, and intersex Americans."
In the Thursday filing, Texas Attorney General Ken Paxton accused the makers of Tylenol of false advertising because the painkiller is promoted as safe to use during pregnancy.
Instagram, Facebook, TikTok, YouTube, and Snapchat's parent companies will be forced to face trial in the claim that they designed social media platforms to addict youths. Trials are set to start in January, after Los Angeles Superior Court Judge Carolyn Kuhl ruled against the companies this week in their last chance to avoid trial.
After weeks of back-and-forth over how much money should be paid out and when, a U.S. district judge set today as the deadline for the government to disburse funds. The administration plans to appeal. Plus, House Speaker Mike Johnson won't ensure a vote on expiring ACA subsidies.
Medicaid's new "GENEROUS" plan would allow participating states to buy certain drugs at prices that align with what is paid in other countries, Fierce Healthcare reported. In separate news, President Donald Trump's weight loss drug announcement was interrupted when an attendee collapsed.
Today's early morning highlights from the major news organizations.
© 2026 KFF